MEDIPHARM LABS CORP (LABS.CA) Stock Price, Forecast & Analysis
Canada - TSX:LABS - CA58504D1006 - Common Stock
LABS.CA Key Statistics, Chart & Performance
The current stock price of LABS.CA is 0.065 CAD. In the past month the price decreased by -18.75%.
LABS.CA Latest News, Press Relases and Analysis
LABS.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.62 | 3.21B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.62B | ||
| CRON.CA | CRONOS GROUP INC | 24.5 | 1.31B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.39 | 884.70M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 5.26 | 623.65M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | 122.2 | 609.04M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 507.38M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 349.88M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 21.03 | 346.12M | ||
| HITI.CA | HIGH TIDE INC | N/A | 331.47M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 292.84M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 238.58M |
Related stock screener links
About LABS.CA
Company Profile
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 161 full-time employees. The company went IPO on 2018-02-09. The firm specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. The company develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets. The firm cultivates and processes cannabis to sell as dried flower, pre-roll and other cannabis products for adult use, medical, and international markets. The firm also provides GMP flower sourcing, packaging, and distribution services for select international clients. Its wholly owned subsidiary Harvest Medicine Inc. operates medical clinics in Canada that provide medical cannabis patients with physician consultations for medical cannabis education and prescriptions. Its international subsidiaries include Beacon Medical Germany GmbH and Beacon Medical Australia Pty Ltd.
Company Info
MEDIPHARM LABS CORP
151 John Street
Barrie ONTARIO L4N 2L1 CA
CEO: Patrick McCutcheon
Employees: 161
Phone: 17057197425
MEDIPHARM LABS CORP / LABS.CA FAQ
What does MEDIPHARM LABS CORP do?
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 161 full-time employees. The company went IPO on 2018-02-09. The firm specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. The company develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets. The firm cultivates and processes cannabis to sell as dried flower, pre-roll and other cannabis products for adult use, medical, and international markets. The firm also provides GMP flower sourcing, packaging, and distribution services for select international clients. Its wholly owned subsidiary Harvest Medicine Inc. operates medical clinics in Canada that provide medical cannabis patients with physician consultations for medical cannabis education and prescriptions. Its international subsidiaries include Beacon Medical Germany GmbH and Beacon Medical Australia Pty Ltd.
Can you provide the latest stock price for MEDIPHARM LABS CORP?
The current stock price of LABS.CA is 0.065 CAD. The price decreased by -7.14% in the last trading session.
Does MEDIPHARM LABS CORP pay dividends?
LABS.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of LABS stock?
LABS.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the Price/Earnings (PE) ratio of MEDIPHARM LABS CORP (LABS.CA)?
MEDIPHARM LABS CORP (LABS.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
Can you provide the growth outlook for MEDIPHARM LABS CORP?
The Revenue of MEDIPHARM LABS CORP (LABS.CA) is expected to grow by 13.37% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is MEDIPHARM LABS CORP worth?
MEDIPHARM LABS CORP (LABS.CA) has a market capitalization of 27.35M CAD. This makes LABS.CA a Nano Cap stock.
LABS.CA Technical Analysis
LABS.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LABS.CA. The financial health of LABS.CA is average, but there are quite some concerns on its profitability.
LABS.CA Financial Highlights
Over the last trailing twelve months LABS.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 22.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.56% | ||
| ROE | -21.74% | ||
| Debt/Equity | 0.01 |
LABS.CA Forecast & Estimates
For the next year, analysts expect an EPS growth of 61.75% and a revenue growth 13.37% for LABS.CA